Mesenchymal stem cells (MSCs) have been considered as an attractive tool for the therapy of diseases. Accumulating evidence indicates that the healing effects of MSCs are mainly related to paracrine action rather than transdifferentiation. Exosomes excreted from MSCs have emerged as physiologically relevant and powerful components of the MSC secretome. However, whether MSC-derived exosomes can improve erectile function of streptozotocin-induced diabetic rats and its mechanism remains unknown. Our previous work showed that adipose tissue-derived stem cells (ADSCs) transplantation could increase endothelial and smooth muscle contents and improve erectile function of diabetic rats. In this study, ADSC-derived exosomes (ADSC-Exo) exhibited in vitro proangiogenic properties, induced the proliferation of endothelial cells and restored erectile function in vivo, as well as decreased fibrosis of corpus cavernosum. In further experiments, we found that ADSC-Exo contained some proangiogenic (miR-126, miR-130a and miR-132) microRNAs and an antifibrotic microRNA family (miR-let7b and miR-let7c). Thus, it is reasonable to postulate that ADSC-Exo transports key functional miRNAs to target cells in a specific manner to improve functional recovery or to activate endogenous repair mechanisms. This proof-of-concept study provides a novel approach for the treatment of diabetic erectile dysfunction.
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| INTRODUCTION
Erectile dysfunction (ED) associated with diabetes mellitus (DM) is a worldwide problem, as epidemiological studies have reported that the incidence of ED in diabetic patients is threefold higher than in non-diabetic persons (Malavige & Levy, 2009; Richardson & Vinik, 2002) . Various mechanisms have been considered to cause diabetic ED (DED), including hyperglycaemia, hypertension, hyperlipidemia, insulin deficiency or insulin resistance, androgen deficiency, vascular and neuronal abnormalities (Gur, Peak, Kadowitz, Sikka, & Hellstrom, 2014; Lue, Brant, Shindel, & Bella, 2000) . In diabetic animal studies, various impairments of the physiological process associated with erection have been reported, including decreased the amount of NO-releasing penile nerves, cavernosal endothelial cells, and smooth muscle content, increased cellular apoptosis of endothelial cells, decreased the expression and activity of neuronal nitric oxide synthase (nNOS) and endothelial nitric oxide synthase (eNOS), and impairs vascular endothelial growth factor (VEGF) signalling and upregulates the RhoA/Rho-Kinase pathway (Alwaal, Zaid, Lin, & Lue, 2015; Matsui, Sopko, Hannan, & Bivalacqua, 2015; Yafi et al., 2016) . Given the low efficacy of oral phosphodiesterase type 5 inhibitor (PDE5i) in these patients, mesenchymal stem cells (MSCs) therapy is an attractive tool for the therapy of DED.
The multipotent differentiation ability of adipose tissue-derived stem cells (ADSCs) has been reported, and it has attracted a lot of attention as a reliable cell source for cellular therapy of DED (Alwaal et al., 2015; Huang, Fu, et al., 2013) . The specific mechanism of these cells is still unknown. However, it has been increasingly observed that the transplanted MSCs did not necessarily engraft and differentiate at the site of injury but might exert their therapeutic effects through paracrine action (Kupcova Skalnikova, 2013) . In our previous study, we restored DED by intracavernous (IC) injection of ADSCs to streptozotocin (STZ)-induced diabetic rats (Zhu et al., 2016) . The results showed that transplanted ADSCs did not express smooth muscle or endothelial cell markers but increase VEGF expression in the corpus cavernosum, suggesting that soluble factors derived from ADSCs might be responsible. However, it is now clear that, in addition to soluble factors, extracellular vesicles (EVs) are a key instrument in cell-cell communication (Mittelbrunn & Sanchez-Madrid, 2012) .
Among the many subtypes of EVs, endosome-derived exosomes have emerged as physiologically relevant and powerful components of the MSC secretome (Baglio, Pegtel, & Baldini, 2012; Kordelas et al., 2014) .
Exosomes are secreted nanosized membrane vesicles with diameters within 40-100 nm. Exosomes contain functional proteins, mRNAs, microRNAs (miRNA) and tRNA species that play important roles in intercellular communication (Kourembanas, 2015; Thery, 2011) . MSCderived exosomes have been identified as therapeutic agents to reduce tissue injury and enhance tissue repair in cases of cardiovascular disease (Bian et al., 2014; Shao et al., 2017) , central nervous system diseases , liver disease , kidney injury (Collino et al., 2015) and diabetic complications (Geiger, Walker, & Nissen, 2015; Nakano et al., 2016) . To our knowledge, whether exosomes derived from ADSCs (ADSC-Exo) can be exploited following transplantation to restore erectile function remains largely unknown.
In this study, we explored the efficacy of IC injection of ADSC-Exo for the treatment of DED and performed in vitro experiments to determine the impacts of ADSC-Exo on endothelial cell proliferation and angiogenesis process. Furthermore, to explain the underlying mechanism of ADSC-Exo treatment, we also performed novel miRNA sequencing in ADSC-Exo and ADSCs. The results of the present study may suggest a novel therapeutic intervention for diabetes-induced erectile dysfunction.
| MATERIAL AND METHODS

| Animals
A total of 36 male, 10-week-old Sprague Dawley rats were obtained from the Animal Breeding Center at the Affiliated Drum Tower Hospital, School of Medicine, Nanjing University, Nanjing, China. The experiments were approved by the Institutional Animal Care and Use Subcommittee of our university. Type 1 diabetes was induced by a single intraperitoneal injected with STZ (65 mg/kg) according to our previously published protocol. (Yu, Wan, Qiu, Chen, & Dai, 2013 ) Controls (Cont, n = 6) were administered an intraperitoneal injection of citrate buffer. STZ-diabetic rats with blood glucose levels of >300 mg/dl (16.6 mmol/L) were used. These rats (24 rats in total) were randomly assigned to three groups, which were treated with 200 μl of PBS containing 0, 10 or 100 μg exosome proteins. At 4 weeks after treatment, all rats underwent erectile function evaluation. The animals were then sacrificed, and the penis was harvested for histology. Blood glucose levels and body weights were monitored regularly during the study.
| Cell culture, exosome isolation and PKH67 labelling
ADSCs were isolated from paratesticular fat of donor rats and cultured as described previously (Zhu et al., 2016) . In brief, passage 3 ADSCs were cultured in complete ADSC medium until 90% confluency; then, the medium was switched to serum-free ADSC medium.
Medium was conditioned by ADSCs for 48 hr and then harvested for exosome isolation.
Human umbilical vein endothelial cells (HUVECs) were obtained from the Type Culture Collection of the Chinese Academy of Sciences, Shanghai, China. They were maintained in Endothelial Cell Growth Medium-2 (EGM-2). The cells were cultured at 37°C in an atmosphere at 5% CO 2 .
Exosomes were isolated from the ADSC-conditioned medium using the exosome precipitation solution, ExoQuick (System Bioscience, Mountain View, CA, USA) according to the manufacturer's protocol.
Exosome capture and internalisation were demonstrated by tracking PKH67 (Sigma-Aldrich, St. Louis, MO, USA)-labelled exosomes inside the cells according to the manufacturer's instructions.
| Transmission electron microscopy
Exosome preparations were mixed with an equal volume of 4% paraformaldehyde in phosphate buffer. Then, 20 μl solution was deposited on 200 mesh formvar-carbon-coated electron microscopy (EM) nickel grids and left to adsorb for 1 min at room temperature. 30 μl phosphotungstic acid solution (20 ml/L) was added on the grids and left to adsorb for 1 min at room temperature, and then, the excess fluid was blotted with filter paper. After drying, grids were examined with a Zeiss EM109 transmission electron microscope (Zeiss, Oberkochen,
Germany). Images were captured using a Nikon digital camera Dmx 1200F (Nikon Corporation, Tokyo, Japan) and ACT-1 software (Nikon Corporation).
| Western blotting
For Western blot analysis, cells were lysed with RIPA buffer containing protease inhibitor cocktail, and the protein concentrations of cell lysates and exosome were determined by BCA assay. Cell lysates and exosome preparations diluted in sample buffer were run on a 10% SDS gel and blotted on a nitrocellulose membrane. Membranes were incubated with monoclonal antibodies against CD9 (Abcam Inc., Cambridge, MA, USA; 1:500), CD63 (Abcam Inc.; 1:500) at room temperature for 4 hr and then for 1 hr at room temperature with anti-rabbit (Calbiochem, San Diego, CA, USA; 1:2,000) secondary antibodies. Detection was performed using enhanced chemiluminescence (Boster, Wuhan, China) followed by autoradiography.
| Cell proliferation assay
The MTT assay (KeyGEN BioTECH, Nanjing, China) was used to assess the proliferation of HUVECs, according to the manufacturer's protocol. Briefly, HUVECs (1 × 10 4 cells/well) were plated onto 96-well plates and treated with ADSC-Exo (final concentrations 0, 1, 10 μg/ml) at 37°C for 24 hr, after which MTT (20 μl, 5 g/L) was added to media and incubated for 4 hr. Subsequently, the supernatant was removed by centrifugation at 1,000 g for 10 min at 4°C, and dimethylsulphoxide was added to solubilise the formazan crystals. Absorbance was measured at 560 nm using an ELISA plate reader.
| Tube formation assay
To mimic an in vivo model for diabetic-induced endothelial dysfunction as described by Yin et al. (Yin et al., 2017) , HUVECs were serum-starved for 24 hr and exposed to the normal (5 mmoL) 
| In vivo implantation of ADSC-Exo
For in vivo experiments, IC transplantation was performed as described previously. (Zhu et al., 2016) All animals were anesthetised with isoflurane, and a 1.5-cm oblique incision was made to expose the penis. The corpus cavernosum was then gently cannulated using a 28-gauge needle. Control rats received an injection of 0.2 ml PBS, and STZ-diabetic rats were randomly assigned to three groups, which were treated with 200 μl of PBS containing 0, 10 or 100 μg exosome proteins. Following the injection, the incision was closed in one layer with an absorbable suture.
| In vivo erectile function assessment
The intracavernous pressure (ICP) response to electric stimulation of the cavernous nerve was measured as described previously (Zhu et al., 2016) . Briefly, the mean arterial pressure (MAP) and ICP were recorded by an RM6042B/C multichannel signal collection processing system (Chengdu Implement Company, Chengdu, China). The peak ICP/MAP ratio was calculated to evaluate erectile function.
| Masson's trichrome stain
Masson's trichome stain was performed according to a previously described protocol (Yu et al., 2013) . Tissues were fixed in 10% formaldehyde, processed routinely for embedding in paraffin. Tissue sections were deparaffinised and hydrated. Nuclei were stained using Weigert's iron haematoxylin for 10 min. After washing with tap water, the samples were stained using 1% ponceau acetic acid solution for 5 min. They were then rinsed rapidly in water and differentiated in 1% phosphomolybdic acid for approximately 5 min. Finally, the slides were counterstained using fast green. The nuclei stained blue, the smooth muscle stained red, and the collagen stained green. The areas of smooth muscle and collagen were analysed using Image-Pro Plus 6.0 (Media Cybernetics, Silver Spring, MD, USA). Six sections of each penile sample were analysed, and the average results were calculated for data analysis.
| Immunohistochemical stain
Immunohistochemical stain was performed to measure endothelial cell content after treatment according to a previously described protocol (Zhu et al., 2016) . Briefly, representative sections were incubated with were analysed, and the average results were calculated for data analysis.
| MicroRNA assay
Cellular and exosome lysates were evaluated for the exosomal cargo.
The methods for purification of microRNAs (miRs) and total RNA and for RNA detection are described elsewhere. ( 
| Data analysis
All data were presented as the mean ± standard deviation. Statistical analysis was carried out by the independent Student's t test and oneway analysis of variance followed by the Tukey-Kramer test for post hoc comparisons using SPSS 16.0 software (SPSS Inc., Chicago, IL, USA). p < .05 was considered statistically significant.
| RESULTS
| General data of diabetes
The rats' body weight and blood glucose levels were shown in Table 1 .
Body weights were significantly lower (p < .05), and blood glucose levels were significantly higher (p < .05) in STZ-diabetic rats than those in the control rats. After ADSC-Exo treatment, body weight and blood glucose levels did not change significantly.
| Analysis of the exosomes secreted by ADSCs
To confirm that the isolated particles were exosomes and not other cellular secretions such as microvesicles or apoptotic bodies, we examined both the size and expression of constitutive exosomal markers. TEM confirmed the size of exosomes (<200 nm) ( Figure 1a ).
The isolated particles expressed exosomal marker CD63 and CD9
( Figure 1b ), confirming that they are indeed exosomes.
| ADSC-derived exosomes exhibited in vitro proangiogenic properties and induced the proliferation of endothelial cells
When PKH67-labelled exosomes were added to media for HUVECs, they were readily absorbed by the cells (Figure 2a ). These findings confirmed that ADSC-Exo was indeed internalised and could transport and deliver their cargo to affect the cell behaviour in the manner indicated by the results of the functional experiments.
In vitro study revealed impairments in tube formation in HUVECs exposed to high-glucose condition. ADSC-Exo showed significant, concentration-dependent proangiogenic activity (Figure 2b,c) . Similar comparative analyses demonstrated that these exosomes significantly enhanced, in a concentration-dependent fashion, the proliferation of HUVECs (Figure 2d ).
| ADSC-derived exosomes reversed corpus cavernosum fibrosis, increased endothelial content and restored erectile function of diabetic rats
Measurements of erectile function in rats of each experimental group are illustrated in 
| ADSC-derived exosomes were enriched with some functional microRNAs
To explore the underlying mechanism of ADSC-Exo on endothelial cell proliferation and angiogenesis process, we also performed novel and functional miRNA sequencing in ADSC-Exo and ADSCs. Three proangiogenic microRNAs including miR-126, miR-130a, miR-132 and an antifibrotic microRNA family miR-let7b and miR-let7c were detected in the cellular and exosome lysates ( Figure 6 ).
| DISCUSSION
Mesenchymal stem cells are a promising therapeutic tool for diseases, including erectile dysfunction (Alwaal et al., 2015) . In recent years, numerous animal studies have demonstrated that ADSCs significantly improve erectile function and alter the microarchitecture of the corpus cavernosum in diabetic rat model (Alwaal et al., 2015) . Further work shows that the mechanism was by secreting a variety of bioactive cytokines, but not differentiating into smooth muscle or endothelial cells. However, ascending evidence indicated that exosomes might T A B L E 1 Body weight and blood glucose (mean ± SD) be the main components of paracrine factors (Derkus, Emregul, & Emregul, 2017) . Besides, given the major concerns of MSC transplantation in clinical practice, such as cell contamination, cell death and immune rejection, exosome-based therapy seems to be an alternative treatment strategy (Derkus et al., 2017) . Taking advantage of some characteristics of the MSC-derived exosomes: (i) they are less immunogenic than parental cells because of lower content of membranebound proteins, such as major histocompatibility complex molecules. (Han et al., 2016; Konala et al., 2016) ; (ii) they can be stored without potentially toxic cryo-preservatives at −20°C for 6 months with no loss of their biochemical activity (Webber & Clayton, 2013) ; (iii) they can protect their contents from degradation in vivo, thereby allowing cargo to travel long distances within tissues without degradation (Eldh et al., 2010) ; (iv) they are devoid of viable cells, and hence, there is no risk of tumour formation. On the contrary, there is the risk of ectopic differentiation of MSCs after systemic infusion (Breitbach et al., 2007) . Research to date indicates that MSC-derived exosomes potentially have more significant clinical utility than MSCs.
In this study, the isolation of exosomes from ADSCs was successful, confirming their diameters at about 40-100 nm and protein expression of CD9 and CD63. In vitro experiment found that ADSCExo promoted endothelial cell proliferation and enhanced angiogenesis. Our histological and functional assessment results reflected that ADSC-Exo inhibited corpus cavernosum fibrosis and improved erectile function in a diabetic model. Importantly, the novel miRNA sequencing results indicated that the expression of these miRNAs in ADSC-Exo was significantly higher than that in ADSCs, which is one of the reasons why ADSC-Exo can replace ADSCs to treat diseases. However, to our knowledge, these novel findings have not been reported before in the context of erectile dysfunction.
MicroRNAs are small non-coding sequences of RNA that have the capacity to regulate many genes, pathways and complex biological (Ding & Sun, 2017) .
MiR-126 belongs to endothelial-specific miRNAs, which plays a significant role in angiogenesis, endothelial cell function and vascular repair (Chistiakov, Orekhov, & Bobryshev, 2016) . MiR-126 represses the expression of SPRED1 and PIK3R2, which negatively regulate VEGF signalling via the ERK and AKT pathways, respectively (Chen & Zhou, 2011) . In diabetic patients, miR-126 in serum samples is most significantly downregulated and that reduced levels of miR-126 is associated with the risk for DM (Zampetaki et al., 2010) . In our previous study, we have demonstrated that VEGF signalling was disrupted in diabetic rats (Zhu et al., 2016) . These findings are consistent with the vasculoprotective function of miR-126.
Moreover, overexpression of miR-126 in ischaemia/reperfusion injury mice model promotes vascular integrity and supports recovery of the kidney (Bijkerk et al., 2014) . In the studies by and Huang, Zhu,et al. (2013) , overexpression of miR-126 promotes the endothelial differentiation of MSCs and further enhances functional angiogenesis of MSCs transplantation in the ischaemic myocardium.
MiR-130a has been shown to play an important role in maintaining endothelial cell proliferation, migration and tubulogenic activity (Chen & Gorski, 2008) . One of pathophysiological mechanisms of DED is endothelial dysfunction. However, it is believed that the damaged endothelium can not only be repaired by the proliferation and migration of neighbouring endothelial cells, but also by endothelial progenitor cells (EPCs) (Traish & Galoosian, 2013; Wassmann, Werner, Czech, & Nickenig, 2006) . Studies have demonstrated that DM reduces the number of EPCs and adversely affects the functional capacity of existing EPCs in patients with ED (Maiorino et al., 2015) . Furthermore, F I G U R E 6 Functional microRNA detection in ADSC-derived exosomes. Three proangiogenic microRNAs including miR-126, miR130a, miR-132 and an antifibrotic microRNA family miR-let7b and miR-let7c were detected in the cellular and exosome lysates. *p < .05 compared with cellular lysates miR-130a has been shown to play an important role in maintaining normal EPC function and decreased miR-130a in EPCs from DM contributes to impaired EPC function, likely via its target Runx3 and through ERK/VEGF and AKT pathways (Meng et al., 2013) .
MiR-132 is highly expressed in the endothelium and exerts proangiogenic, prosurvival and antifibrotic activity via inhibition of its targets RasGAP and MeCP2 (Anand et al., 2010; Katare et al., 2011) .
Moreover, the cardioprotective role of miR-132 in the exosomes derived from human cardiac progenitor cells (CPCs) has been reported (Barile et al., 2014) . Apart from the endothelium, miR-132 is also expressed in neuronal cells and regulates the differentiation of dopamine neurons by directly targeting Nurr1 expression (Yang et al., 2012) .
Mesenchymal stem cells secrete microparticles or exosomes enriched with pre-miRNAs, and the miRNA expression profile of MSCs is associated with a high expression of the miR-let7 family suggesting that miR-let7 derived from MSCs may play a protective role in tissue injury and disease (Baglio et al., 2015) . Under fibrotic conditions including renal fibrosis resulting from DM and idiopathic pulmonary fibrosis (Pandit et al., 2010) , miR-let7 family (miR-let7b and miR-let7c) are strongly downregulated. And other researchers have identified the antifibrotic role of the miR-let7 family (miR-let7b and miRlet7c) through regulation of TGF-β signalling .
In current study, our results showed high expression of miR-126, miR-130a, miR-132, miR-let7b and miR-let7c in ADSC-Exo. Thus, it is reasonable to postulate that ADSC-Exo transports key functional miRNAs to target cells in a specific manner to improve functional recovery or to activate endogenous repair mechanisms. Certainly, we need to identify the exact targets of the miRNAs and define the pathways in future studies in order to better understand how these miRNA might affect the efficacy of stem cells. Moreover, in our study, using primary cultured cavernous endothelial cells seemed to be more meaningful than using HUVECs. It is a limitation of our study.
| CONCLUSIONS
Together, our data indicate that ADSC-derived exosomes exhibited proangiogenic properties and induced the proliferation of endothelial cells in vitro, decreased fibrosis and restored erectile function in vivo.
In further experiments, we found that ADSC-Exo contained some proangiogenic (miR-126, miR-130a and miR-132) microRNAs and an antifibrotic microRNA family (miR-let7b and miR-let7c). This proof-ofconcept study provides a novel approach for the treatment of diabetic erectile dysfunction.
